VBI Vaccines Inc

VBI Vaccines Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company employs 63 people and generated $3 million in revenue. VBI Vaccines focuses on developing innovative vaccines and immunotherapies. VBI Vaccines specializes in virus-like particle ("VLP") technology, including a proprietary enveloped VLP ("eVLP") platform. Their vaccine candidates are designed to mimic the natural presentation of viruses, stimulating the human immune system to fight diseases. The company's pipeline targets a range of diseases, including hepatitis B, COVID-19 and coronaviruses, cytomegalovirus (CMV), and aggressive cancers like glioblastoma (GBM). Research operations for VBI Vaccines are located in Ottawa, Canada, and the company maintains a research and manufacturing site in Rehovot, Israel. For more information, visit www.vbivaccines.com. News and insights can be found at www.vbivaccines.com/news-and-resources/, investor information is available at www.vbivaccines.com/investors/, and job opportunities are listed at www.vbivaccines.com/careers/.